Clinic
Agh Laveen LLC
Agh Laveen LLC was paid $3.40M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoAGH LAVEEN LLC
GLENDALE, AZ 85302
GLENDALE, AZ 85302
33aNPI1275084030assigned 10/17/2016
33bProvider typeEmergency Care Clinic/Center
28Total paid$3.40M
24GClaims54,714
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Arizona
Rank by total paid#9 of 28
Median peer was paid$2.32M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HANSON, JANE controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,469 | $522K | |
| 2019 | 4,549 | $375K | |
| 2020 | 2,133 | $260K | |
| 2021 | 1,423 | $191K | |
| 2022 | 198 | $14K | |
| 2023 | 2,078 | $110K | |
| 2024incomplete | 36,864 | $1.93M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 7,215 | 6,920 | $1.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 5,026 | 4,837 | $1.17M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 1,535 | 1,468 | $501K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.8% | 434 | 425 | $196K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.9% | 291 | 290 | $168K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 924 | 906 | $85K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 275 | 273 | $54K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 61 | 61 | $14K |
| 10060 | <1% | 41 | 39 | $9K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 13 | 13 | $6K |
| 72131 | <1% | 16 | 16 | $5K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 57 | 54 | $2K |
91 more codes
| 70486 | <1% | 13 | $1K | |
| 71250 | <1% | 40 | $809.01 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 873 | $553.96 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,827 | $99.64 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,211 | $82.46 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,388 | $63.87 |
| 80053 | Comprehensive metabolic panel | <1% | 2,547 | $35.27 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,629 | $13.74 |
| 81025 | <1% | 1,535 | $13.32 | |
| J3490 | Unclassified drugs | <1% | 534 | $10.39 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,170 | $9.12 |
| 82550 | <1% | 599 | $8.82 | |
| 80076 | <1% | 401 | $7.35 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,499 | $7.15 |
| 80051 | <1% | 599 | $6.31 | |
| 81003 | <1% | 3,152 | $5.93 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 139 | $5.26 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 215 | $4.91 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 206 | $4.46 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 347 | $0.17 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 196 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,856 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 168 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 410 | $0.00 |
| 82803 | 0% | 222 | $0.00 | |
| 76801 | 0% | 103 | $0.00 | |
| 83605 | 0% | 238 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 265 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 53 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 1,501 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 599 | $0.00 |
| 84484 | 0% | 370 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 42 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 136 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 46 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,146 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 109 | $0.00 |
| 84703 | 0% | 612 | $0.00 | |
| 82150 | 0% | 45 | $0.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 155 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 528 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 181 | $0.00 |
| 85379 | 0% | 102 | $0.00 | |
| 93971 | 0% | 42 | $0.00 | |
| 87428 | 0% | 84 | $0.00 | |
| 82962 | 0% | 74 | $0.00 | |
| 12001 | 0% | 40 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 15 | $0.00 |
| 83880 | 0% | 126 | $0.00 | |
| 96376 | 0% | 32 | $0.00 | |
| 87480 | 0% | 32 | $0.00 | |
| 87510 | 0% | 32 | $0.00 | |
| 87077 | 0% | 50 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 12 | $0.00 |
| A9270 | Non-covered item or service | 0% | 39 | $0.00 |
| 82947 | 0% | 527 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 196 | $0.00 |
| 87634 | 0% | 124 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 546 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 0% | 1,066 | $0.00 |
| 87631 | 0% | 1,045 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 616 | $0.00 |
| 87420 | 0% | 13 | $0.00 | |
| 80306 | 0% | 265 | $0.00 | |
| 82565 | 0% | 538 | $0.00 | |
| 73130 | 0% | 159 | $0.00 | |
| 74018 | 0% | 116 | $0.00 | |
| 73110 | 0% | 59 | $0.00 | |
| 90715 | 0% | 109 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 114 | $0.00 |
| 81513 | 0% | 41 | $0.00 | |
| 93976 | 0% | 61 | $0.00 | |
| 73080 | 0% | 46 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 85 | $0.00 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 55 | $0.00 |
| 73562 | 0% | 127 | $0.00 | |
| 84520 | 0% | 537 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 43 | $0.00 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 74 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 105 | $0.00 |
| 73630 | 0% | 168 | $0.00 | |
| 73610 | 0% | 123 | $0.00 | |
| 73030 | 0% | 56 | $0.00 | |
| 87186 | 0% | 35 | $0.00 | |
| 87660 | 0% | 32 | $0.00 | |
| 85610 | 0% | 13 | $0.00 | |
| 87481 | 0% | 41 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 14 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 12 | $0.00 |
| 84702 | 0% | 65 | $0.00 | |
| 72100 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANSON, JANE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Agh Laveen LLC | Laveen, AZ | $109.33M |
| Agh Mesa LLC | Mesa, AZ | $28.01M |
| Agh Laveen LLC | Glendale, AZ | $14.88M |
| Agh Mesa LLC | Mesa, AZ | $4.69M |
| Agh Laveen LLC | Goodyear, AZ | $4.04M |
| Agh Laveen LLC | Surprise, AZ | $3.48M |
| Agh Mesa LLC | Tempe, AZ | $3.34M |
| Agh Mesa LLC | Chandler, AZ | $2.76M |
| Agh Mesa LLC | Mesa, AZ | $2.66M |
| Agh Mesa LLC | San Tan Valley, AZ | $2.32M |
| Agh Mesa LLC | Phoenix, AZ | $1.74M |
| Agh Mesa LLC | Chandler, AZ | $1.12M |
| Agh Mesa LLC | Gilbert, AZ | $978K |
| Agh Laveen LLC | Mesa, AZ | $293K |
| Agh Laveen LLC | Chandler, AZ | $259K |
| Agh Laveen LLC | Phoenix, AZ | $184K |
| Agh Laveen LLC | Mesa, AZ | $167K |
| Agh Laveen LLC | Gilbert, AZ | $160K |
| Agh Laveen LLC | Chandler, AZ | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.